Biogen Inc BIIB
Dividend Summary
The previous Biogen Inc dividend was 0c and it went ex almost 15 years ago and it was paid almost 15 years ago.
There have not been any declared dividends recently.
Summary | Previous dividend | Next dividend |
---|---|---|
Status | Paid | – |
Type | Final | – |
Per share | 0c | – |
Declaration date | – | – |
Ex-div date | 31 Dec 2009 (Thu) | – |
Pay date | 31 Dec 2009 (Thu) | – |
Enter the number of Biogen Inc shares you hold and we'll calculate your dividend payments:
Sign up for Biogen Inc and we'll email you the dividend information when they declare.
Add Biogen Inc to receive free notifications when they declare their dividends.
Your account is set up to receive Biogen Inc notifications.
Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
---|---|---|---|---|---|---|---|---|
Paid | Final | – | 31 Dec 2009 | 31 Dec 2009 | USD | — | 0c | |
Paid | Final | – | 31 Dec 2008 | 31 Dec 2008 | USD | — | 0c | |
Paid | Final | – | 31 Dec 2007 | 31 Dec 2007 | USD | — | 0c | |
Paid | Final | – | 31 Dec 2006 | 31 Dec 2006 | USD | — | 0c |
Year | Amount | Change |
---|---|---|
2006 | 0.0c | — |
2007 | 0.0c | 0% |
2008 | 0.0c | 0% |
2009 | 0.0c | 0% |
Biogen Inc Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 11 December 2023
- 52 Week Low
- 0.0% on 11 December 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About Biogen Inc
In November 2003, Biogen and IDEC Pharmaceuticals finalised their $6bn merger, creating Biogen Idec, the third-largest biotechnology company in the world. The company is now a global leader in the development, manufacturing, and commercialisation of novel therapies. Its major products include treatments for relapsing multiple sclerosis, certain B-cell non-Hodgkin's lymphomas and adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
From their web site: "Biogen Idec does not pay a dividend..."
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United States
- Share Price
- $156.46 (yesterday's closing price)
- Shares in Issue
- 146 million
- Market Cap
- $22.8bn
- 0
- Market Indices
- NASDAQ 100, S&P 100, S&P 500
- Home Page URL
- https://www.biogen.com/
- Investor Relations URL
- Sign Up Required
- Financial Calendar URL
- Sign Up Required